Medtronic Sustainability Profile
Medtronic plc, a global leader in medical technology, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1949, the company has pioneered advancements in various medical fields, including cardiovascular, diabetes, and neurological care. Medtronic is renowned for its innovative core products, such as insulin pumps, cardiac devices, and surgical instruments, which are designed to improve patient outcomes and enhance quality of life. The company’s commitment to research and development has positioned it as a market leader, with notable achievements including the first successful implant of a cardiac pacemaker. With a strong focus on patient-centric solutions, Medtronic continues to set industry standards, making significant contributions to healthcare worldwide.
DitchCarbon Score
How does Medtronic's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medtronic's score of 50 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medtronic's reported carbon emissions
In 2023, Medtronic reported total greenhouse gas emissions of approximately 256,800,000 kg CO2e, comprising 131,500,000 kg CO2e from Scope 1 and 125,200,000 kg CO2e from Scope 2 emissions. The company has set ambitious targets to reduce its carbon footprint, committing to a 52% reduction in absolute Scope 1 and Scope 2 emissions by 2030, using a 2020 baseline. Additionally, Medtronic aims to achieve a 37.5% reduction in Scope 3 emissions, which include upstream transportation and distribution, business travel, and end-of-life treatment of sold products, by 2034 from a 2024 baseline. Medtronic is also focused on increasing its renewable electricity sourcing from 1.29% in FY2020 to 100% by FY2030. The company has committed to ensuring that 75% of its suppliers, based on emissions from purchased goods and services and capital goods, will have science-based targets by 2030. Furthermore, Medtronic has pledged to achieve net-zero emissions across all scopes by 2050. The emissions data and reduction targets are sourced from Medtronic plc, with no cascading from a parent organization. The company's initiatives align with the Science Based Targets initiative (SBTi) and reflect its commitment to addressing climate change within the healthcare sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 74,992,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 269,008,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | - |
How Carbon Intensive is Medtronic's Industry?
How Carbon Intensive is Medtronic's Location?
Medtronic's Scope 3 Categories Breakdown
Medtronic's Scope 3 emissions, which increased by 48% last year and increased by approximately 48% since 2021, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 55% of total emissions under the GHG Protocol, with "Downstream Transportation & Distribution" being the largest emissions source at 47% of Scope 3 emissions.
Top Scope 3 Categories
Medtronic's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medtronic has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Abbott
Frequently Asked Questions
Common questions about Medtronic's sustainability data and climate commitments